4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-15-060513
CIK 0001270073operating
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 9:00 PM ET
Size
8.4 KB
Accession
0001144204-15-060513
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Sale
Common Stock
2015-10-20$182.22/sh−974$177,482→ 962 total - Exercise/Conversion
Common Stock
2015-10-20$9.82/sh+974$9,567→ 1,936 total - Exercise/Conversion
Options to Purchase Common Stock
2015-10-20−974→ 1,947 totalExercise: $9.82Exp: 2019-09-16→ Common Stock (974 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
- [F2]All shares underlying this option have vested.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 9:00 PM ET
- Size
- 8.4 KB